PLEXIFORM NEUROFIBROMAS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Plexiform Neurofibromas Treatment Market, By Drug Class (Selumetinib, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anticonvulsants, Others (Tricyclic Antidepressants, etc.)), By Patient Population (Pediatric, Adult), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 31 Mar, 2026
Code: CMI5430
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Plexiform neurofibromas is an uncommon variant of neurofibromatosis type 1 that arises from multiple nerves as bulging and deforming masses involving also connective tissue and skin folds. Neurofibromatosis is a genetic neurological disorder which can affect the skin, nerves, brain, and spinal cord. Neurofibromas or tumors, grow along the body's nerves or on or underneath the skin. There are three types of neurofibromatosis that are associated with unique symptoms and signs, Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2), and Schwannomatosis. Plexiform neurofibromas are essentially pathognomonic of neurofibromatosis type 1 (NF1) which is a common complication of neurofibromatosis. Plexiform neurofibromas are predominantly inherited tumors that can occur anywhere in the body. This includes the head and neck, extremities, areas around the spine and deep in the body where they may affect organs. Plexiform neurofibromas are usually diagnosed in early childhood. They are found in approximately 30% of patients with NF1. Plexiform neurofibromas diffusely involve long nerve segments and its branches, often extending beyond the epineurium into the surrounding tissue.

Market Dynamics

Adoption of inorganic strategies, such as product approval, by regulatory authority such as the U.S. Food and Drug Administration is expected to drive the global plexiform neurofibromas treatment market growth over the forecast period. For instance, in April 2020, AstraZeneca, a biopharmaceutical company, announced that they had received an approval from the U.S. Food and Drug Administration for Selumetinib under the brand name Koselugo, for pediatric patients, 2 years of age and older, with neurofibromatosis type 1. Selumetinib is a kinase inhibitor and the first therapy approved for pediatric patients with neurofibromatosis.

Key features of the study

This report provides an in-depth analysis of the global plexiform neurofibromas treatment market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global plexiform neurofibromas treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AstraZeneca, Pfizer Inc., Sun Pharmaceuticals Industries Limited, Mallinckrodt Pharmaceuticals, SpringWorks Therapeutics, Alcaliber S.A, Teva Pharmaceutical Industries Ltd., Glenmark, Amneal Pharmaceuticals LLC, Aurobindo Pharma, Apotex Inc., Mylan N.V., GSK plc., Solara Active Pharma Sciences Ltd., Abbott, Shanghai Kechow Pharma, Inc., Endo Pharmaceuticals Inc., Purdue Pharma L.P, Merck & Co., Inc., NFlection Therapeutics, Healx, and Array Biopharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global plexiform neurofibromas treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plexiform neurofibromas treatment market

Market Segmentation

By Drug Class (Revenue, USD Mn, 2020 - 2033)
- Selumetinib
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Anticonvulsants
- Others (Tricyclic Antidepressants, etc.)
By Application Insights (Revenue, USD Mn, 2020 - 2033)
- Pediatric
- Adult
By End User Insights (Revenue, USD Mn, 2020 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region Insights (Revenue, USD Mn, 2020 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East & Africa
  - GCC Countries
  - Israel
  - Rest of Middle East & Africa
Key Players
- AstraZeneca
- Pfizer Inc.
- Sun Pharmaceuticals Industries Limited
- Mallinckrodt Pharmaceuticals
- SpringWorks Therapeutics
- Alcaliber S.A
- Teva Pharmaceutical Industries Ltd.
- Glenmark, Amneal Pharmaceuticals LLC
- Aurobindo Pharma
- Apotex Inc.
- Mylan N.V.
- GSK plc.
- Solara Active Pharma Sciences Ltd.
- Abbott
- Shanghai Kechow Pharma, Inc.
- Endo Pharmaceuticals Inc.
- Purdue Pharma L.P.
- Merck & Co., Inc.
- NFlection Therapeutics
- Healx
- Array Biopharma

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snapshot, By Drug Class
Market Snapshot, By Patient Population
Market Snapshot, By Distribution Channel
Market Snapshot, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Impact Analysis
Market Trends
PEST Analysis
PORTER’s Analysis
Key Developments
Brand Analysis
Merger and Collaboration Scenario
Epidemiology
Product Approvals/Launches
Treatment Algorithm
Treatment Option Analysis
Site of Activity (Mode of Action)
New Investments by Major Market Players
Manufacturer Revenue
Disease Awareness Programs
Healthcare Spending by Country

Global Plexiform Neurofibromas Treatment Market, By Drug Class, 2020–2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends

Selumetinib

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Anticonvulsants

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Others (Tricyclic Antidepressants, etc.)

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Global Plexiform Neurofibromas Treatment Market, By Patient Population, 2020–2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends

Pediatric

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Adult

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Global Plexiform Neurofibromas Treatment Market, By Distribution Channel, 2020–2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends

Hospital Pharmacies

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Retail Pharmacies

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Online Pharmacies

Overview
Market Size and Forecast, and Y-o-Y Growth, 2020–2033, (USD Mn)

Global Plexiform Neurofibromas Treatment Market, By Region, 2020–2033, (USD Mn)

Introduction

Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2033
Regional Trends

North America

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn)

U.S.

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Canada

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Latin America

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn)

Brazil

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Mexico

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Argentina

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Rest of Latin America

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Europe

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn)

U.K.

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Germany

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Italy

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

France

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Spain

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Russia

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Rest of Europe

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Asia Pacific

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn)

China

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

India

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Japan

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

ASEAN

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Australia

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

South Korea

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Rest of Asia Pacific

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Middle East

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2033, (USD Mn)

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Israel

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Rest of Middle East

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Africa

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020–2033, (USD Mn)

North Africa

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Central Africa

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

South Africa

Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Population, 2020 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (USD Mn)

Competitive Landscape

AstraZeneca

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Pfizer Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Sun Pharmaceuticals Industries Limited

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Mallinckrodt Pharmaceuticals

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

SpringWorks Therapeutics

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Alcaliber S.A

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Teva Pharmaceutical Industries Ltd.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Glenmark

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Amneal Pharmaceuticals LLC

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Aurobindo Pharma

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Apotex Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Mylan N.V.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

GSK plc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Solara Active Pharma Sciences Ltd.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Abbott

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Shanghai Kechow Pharma, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Endo Pharmaceuticals Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Purdue Pharma L.P

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Merck & Co., Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

NFlection Therapeutics

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Healx

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Array Biopharma

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Section

Research Methodology
About Us

*Browse 113 market data tables and 50 figures on "Global Plexiform Neurofibromas Treatment Market” - forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now